NSC |
Compound |
Enrichment |
Correlation |
NSC 718781 |
Erlotinib hydrochloride |
0.029142074732756 |
-0.23746698 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.029142074732756 |
0.44835479 |
NSC 729166 |
N,N'-didecyl 4,4'-(1,4-piperazinediyl)bisbenzenecarboximidamide |
0.029142074732756 |
0.14139781 |
NSC 731704 |
1-[4-Ethoxycarbonyl)homopiperazine-1-yl]diazen-1-ium-1,2-dio late. |
0.029142074732756 |
0.40721068 |
NSC 732936 |
5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.029142074732756 |
0.31866142 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.029142074732756 |
0.4262686 |
NSC 748902 |
[(20S)-20-(N,N-dimethylamino)- 3a-(tigloylamino)-5a-preg-2a-ol] |
0.029142074732756 |
0.33913963 |
NSC 749600 |
Null |
0.029142074732756 |
0.34057201 |
NSC 751605 |
(E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide |
0.029142074732756 |
0.44165515 |
NSC 752761 |
Null |
0.029142074732756 |
-0.043097797 |